Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Lantheus Holdings Inc LNTH

Healthcare Medical Instruments & Supplies
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company. The Company is engaged in delivering science to enable clinicians to find, fight and follow disease to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:LNTH)

Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time

GlobeNewswire 6 days ago

Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024

GlobeNewswire March 5, 2024

Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients

GlobeNewswire March 4, 2024

Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer

GlobeNewswire February 28, 2024

Lantheus to Present at the TD Cowen 44th Annual Health Care Conference

GlobeNewswire February 26, 2024

Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire February 22, 2024

Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on Aging

GlobeNewswire February 13, 2024

Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern Time

GlobeNewswire February 8, 2024

Lantheus Announces CEO Succession Plan

GlobeNewswire January 23, 2024
View More News ››

Opinion & Analysis (NDAQ:LNTH)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:LNTH)

Lantheus Announces CEO Succession Plan | Benzinga

Just In: $LNTH Lantheus Announces CEO Succession Plan | BenzingaLantheus Board Member and Pharmaceutical Industry Veteran Brian Markison...
whytestocks - January 23, 2024
View more Bullboard ››

Calima Energy Ord Shs

Calima Energy Ord Shs

Calima Energy Limited is an Australia-based production-focused energy company. The Company is engaged in the exploration and ...
View More »